Amaran Biotechnology

About Amaran Biotechnology

Founded in 2010, Amaran Biotechnology, Inc. is a privately-held biopharmaceuticals manufacturer engaged in the design, development and manufacture of pharmaceutical and biotechnology products, including KLH-conjugated active immunotherapies such as Adagloxad Simolenin, the lead immunotherapy product of OBI Pharma, Inc., a publicly-traded Taiwan biotech company. Amaran corporate headquarters are based in Zhubei City, Taiwan.
YEAR FOUNDED:
2010
LEADERSHIP:
General Manager and Chair of of the Board: Tessie Che
Director of Business Development : Brian Stamper